CD226 and glioblastoma: In a seminal study, Choi and colleagues [32] demonstrated using an orthotopic mouse model that intratumoral administration of allogeneic γδ T lymphocytes elicits anti-GBM responses through DNAX accessory molecule-1 (DNAM-1)-dependent mechanisms.